X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
blasting (10) 10
heating (10) 10
lighting (10) 10
mechanical engineering (10) 10
weapons (10) 10
humans (8) 8
performing operations (8) 8
transporting (8) 8
fixed constructions (7) 7
index medicus (7) 7
physical or chemical processes or apparatus in general (7) 7
chemistry (6) 6
heat exchange in general (6) 6
metallurgy (6) 6
multiple sclerosis (6) 6
models, biological (5) 5
treatment of water, waste water, sewage, or sludge (5) 5
building (4) 4
chemical or physical processes, e.g. catalysis or colloidchemistry (4) 4
female (4) 4
human necessities (4) 4
male (4) 4
measuring (4) 4
multiple sclerosis, relapsing-remitting - drug therapy (4) 4
pharmacology & pharmacy (4) 4
physics (4) 4
testing (4) 4
their relevant apparatus (4) 4
agriculture (3) 3
analysis (3) 3
animal husbandry (3) 3
antibodies, monoclonal, humanized - pharmacokinetics (3) 3
area under curve (3) 3
ceilings (3) 3
details of heat-exchange and heat-transfer apparatus, ofgeneral application (3) 3
drug administration schedule (3) 3
fishing (3) 3
floors (3) 3
forestry (3) 3
general building constructions (3) 3
hunting (3) 3
insulation or other protection of buildings (3) 3
interferon-beta - pharmacokinetics (3) 3
interferon-beta - therapeutic use (3) 3
investigating or analysing materials by determining theirchemical or physical properties (3) 3
longitudinal count data (3) 3
middle aged (3) 3
mixture model (3) 3
polyethylene glycols - pharmacokinetics (3) 3
polyethylene glycols - therapeutic use (3) 3
population pharmacokinetics (3) 3
roofs (3) 3
separation (3) 3
trapping (3) 3
treatment outcome (3) 3
walls, e.g. partitions (3) 3
adjuvants, immunologic - administration & dosage (2) 2
adjuvants, immunologic - pharmacokinetics (2) 2
adjuvants, immunologic - therapeutic use (2) 2
adult (2) 2
advance (2) 2
aged (2) 2
animals (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antibodies, monoclonal, humanized - blood (2) 2
biocides, e.g. as disinfectants, as pesticides, as herbicides (2) 2
biological-activities (2) 2
care and treatment (2) 2
cd25 occupancy (2) 2
cd56 (2) 2
chemistry, multidisciplinary (2) 2
combination therapy (2) 2
contrast media - administration & dosage (2) 2
count data (2) 2
cultivation of vegetables, flowers, rice, fruit, vines, hopsor seaweed (2) 2
daclizumab hyp (2) 2
derivatives (2) 2
doors, windows, shutters, or roller blinds in general (2) 2
dose-response relationship, drug (2) 2
drugs (2) 2
engineering, chemical (2) 2
engineering, environmental (2) 2
exposure–response (2) 2
fixed or movable closures for openings in buildings, vehicles,fences or like enclosures in general, e.g. doors, windows,blinds, gates (2) 2
functional features or details of lighting devices or systemsthereof (2) 2
gadolinium - administration & dosage (2) 2
general tagging of cross-sectional technologies spanning over several sections of the ipc (2) 2
general tagging of new technological developments (2) 2
half-life (2) 2
heat-exchange apparatus, not provided for in another subclass,in which the heat-exchange media do not come into direct contact (2) 2
horticulture (2) 2
image enhancement (2) 2
immunoglobulin g (2) 2
injections, subcutaneous (2) 2
interferon-beta - administration & dosage (2) 2
ladders (2) 2
light sources not otherwise provided for (2) 2
light sources using charges of combustible material (2) 2
light sources using electrochemiluminescence (2) 2
light sources using semiconductor devices as light-generatingelements (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 08/2016, Volume 537, Issue 7618, pp. 50 - 56
Journal Article
Journal of Physics: Conference Series, ISSN 1742-6588, 11/2017, Volume 910, Issue 1, p. 12033
Conference Proceeding
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 08/2017, Volume 57, Issue 8, pp. 1005 - 1016
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 11/2016, Volume 82, Issue 5, pp. 1333 - 1342
Daclizumab high yield process (HYP) is a humanized IgG1 monoclonal antibody that binds to the [alpha]-subunit of the interleukin-2 receptor and is being... 
regulatory T cells | daclizumab HYP | NK cells | multiple sclerosis | bright | CD25 occupancy | CD56 | PK–PD | Multiple sclerosis | Daclizumab HYP | PK-PD | Regulatory T cells | Killer cells | Interleukins | Analysis | Immunoglobulin G | Monoclonal antibodies | T cells | Index Medicus | Pharmacokinetic Dynamic Relationships | CD56bright NK cells
Journal Article
Nature, ISSN 0028-0836, 09/2016, Volume 537, Issue 7618, p. 50
Alzheimer's disease (AD) is characterized by deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain, accompanied by synaptic dysfunction... 
Monoclonal antibodies | Physiological aspects | Care and treatment | Amyloidosis | Alzheimer's disease | Studies | Brain | Immunoglobulins | Medical imaging | Sensitivity analysis | Transgenic animals | Rodents | Memory | Alzheimers disease
Journal Article
Journal of Pharmacokinetics and Pharmacodynamics, ISSN 1567-567X, 8/2016, Volume 43, Issue 4, pp. 371 - 383
The effect of subcutaneous (SC) peginterferon β-1a exposure on reduction of gadolinium-enhanced (Gd+) lesion count over time was evaluated in patients with... 
Biomedical Engineering | Biochemistry, general | Population pharmacokinetics | Multiple sclerosis | Biomedicine | Peginterferon β-1a | Pharmacy | Exposure–response | Mixture model | Veterinary Medicine | Longitudinal count data | Pharmacology/Toxicology | Index Medicus | Original Paper
Journal Article
Journal of Pharmacokinetics and Pharmacodynamics, ISSN 1567-567X, 08/2016, Volume 43, Issue 4, p. 371
The effect of subcutaneous (SC) peginterferon [beta]-1a exposure on reduction of gadolinium-enhanced (Gd+) lesion count over time was evaluated in patients... 
Journal Article
Chemical Engineering Journal, ISSN 1385-8947, 10/2018, Volume 349, pp. 129 - 145
Journal Article
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, ISSN 1567-567X, 08/2016, Volume 43, Issue 4, pp. 371 - 383
The effect of subcutaneous (SC) peginterferon beta-1a exposure on reduction of gadolinium-enhanced (Gd+) lesion count over time was evaluated in patients with... 
Population pharmacokinetics | PEGYLATED INTERFERON BETA-1A | COUNT DATA | Multiple sclerosis | SAFETY | Mixture model | Exposure-response | MODEL | Peginterferon beta-1a | Longitudinal count data | PHARMACOLOGY & PHARMACY | ADVANCE | NONMEM
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.